Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study)

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Knorr, S, Bytoft, B, Lohse, Z, Boisen, AB, Clausen, TD, Jensen, RB, Damm, P, Beck-Nielsen, H, Holst, JJ, Hartmann, B, Møller, HJ, Højlund, K, Gravholt, CH & Jensen, DM 2019, 'Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study)' Diabetes Care, vol. 42, no. 8, pp. 1560-68. https://doi.org/10.2337/dc19-0571

APA

CBE

Knorr S, Bytoft B, Lohse Z, Boisen AB, Clausen TD, Jensen RB, Damm P, Beck-Nielsen H, Holst JJ, Hartmann B, Møller HJ, Højlund K, Gravholt CH, Jensen DM. 2019. Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). Diabetes Care. 42(8):1560-68. https://doi.org/10.2337/dc19-0571

MLA

Vancouver

Author

Knorr, Sine ; Bytoft, Birgitte ; Lohse, Zuzana ; Boisen, Anne B ; Clausen, Tine D ; Jensen, Rikke B ; Damm, Peter ; Beck-Nielsen, Henning ; Holst, Jens J ; Hartmann, Bolette ; Møller, Holger J ; Højlund, Kurt ; Gravholt, Claus H ; Jensen, Dorte M. / Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). In: Diabetes Care. 2019 ; Vol. 42, No. 8. pp. 1560-68.

Bibtex

@article{8825680f04e64539b7ccdb74a4e06d17,
title = "Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study)",
abstract = "OBJECTIVE: Intrauterine exposure to maternal type 1 diabetes is associated with a less favorable metabolic profile later in life. Nonalcoholic fatty liver disease is the hepatic manifestation of a cluster of metabolic abnormalities linked to insulin resistance. This study aimed to evaluate the effect of maternal pregestational type 1 diabetes on the presence of fatty liver in offspring and the association between maternal BMI, glycemic control during pregnancy, offspring metabolic risk factors, and offspring level of soluble CD163 (sCD163; a marker of macrophage activation) and risk of fatty liver.RESEARCH DESIGN AND METHODS: This study was a prospective nationwide follow-up study of offspring (n = 278) of mothers with pregestational type 1 diabetes between 1993 and 1999 and matched control subjects (n = 303). Mean age at the time of follow-up was 16.7 years (range 13.0-20.4 years). We used the fatty liver index (FLI) and waist-to-height ratio (WHtR) to evaluate the presence of fatty liver among the offspring. An FLI ≥60 or WHtR >0.469 were used as cutoff points for fatty liver.RESULTS: More type 1 diabetes-exposed offspring had high FLI and WHtR indices compared with unexposed control subjects. We found significant associations between increasing maternal prepregnancy BMI, being born large for gestational age, offspring level of sCD163, as well as offspring metabolic risk factors (decreasing adiponectin and HDL cholesterol and increasing leptin, HOMA of insulin resistance, and HOMA of insulin secretion) and degree of fatty liver.CONCLUSIONS: Intrauterine exposure to maternal type 1 diabetes and higher maternal prepregnancy BMI may predispose to fatty liver in the offspring. Offspring metabolic risk factors, including sCD163 levels, are associated with indices of fatty liver.",
author = "Sine Knorr and Birgitte Bytoft and Zuzana Lohse and Boisen, {Anne B} and Clausen, {Tine D} and Jensen, {Rikke B} and Peter Damm and Henning Beck-Nielsen and Holst, {Jens J} and Bolette Hartmann and M{\o}ller, {Holger J} and Kurt H{\o}jlund and Gravholt, {Claus H} and Jensen, {Dorte M}",
note = "{\circledC} 2019 by the American Diabetes Association.",
year = "2019",
month = "6",
day = "4",
doi = "10.2337/dc19-0571",
language = "English",
volume = "42",
pages = "1560--68",
journal = "International Journal of MS Care",
issn = "1935-5548",
publisher = "American Diabetes Association",
number = "8",

}

RIS

TY - JOUR

T1 - Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study)

AU - Knorr, Sine

AU - Bytoft, Birgitte

AU - Lohse, Zuzana

AU - Boisen, Anne B

AU - Clausen, Tine D

AU - Jensen, Rikke B

AU - Damm, Peter

AU - Beck-Nielsen, Henning

AU - Holst, Jens J

AU - Hartmann, Bolette

AU - Møller, Holger J

AU - Højlund, Kurt

AU - Gravholt, Claus H

AU - Jensen, Dorte M

N1 - © 2019 by the American Diabetes Association.

PY - 2019/6/4

Y1 - 2019/6/4

N2 - OBJECTIVE: Intrauterine exposure to maternal type 1 diabetes is associated with a less favorable metabolic profile later in life. Nonalcoholic fatty liver disease is the hepatic manifestation of a cluster of metabolic abnormalities linked to insulin resistance. This study aimed to evaluate the effect of maternal pregestational type 1 diabetes on the presence of fatty liver in offspring and the association between maternal BMI, glycemic control during pregnancy, offspring metabolic risk factors, and offspring level of soluble CD163 (sCD163; a marker of macrophage activation) and risk of fatty liver.RESEARCH DESIGN AND METHODS: This study was a prospective nationwide follow-up study of offspring (n = 278) of mothers with pregestational type 1 diabetes between 1993 and 1999 and matched control subjects (n = 303). Mean age at the time of follow-up was 16.7 years (range 13.0-20.4 years). We used the fatty liver index (FLI) and waist-to-height ratio (WHtR) to evaluate the presence of fatty liver among the offspring. An FLI ≥60 or WHtR >0.469 were used as cutoff points for fatty liver.RESULTS: More type 1 diabetes-exposed offspring had high FLI and WHtR indices compared with unexposed control subjects. We found significant associations between increasing maternal prepregnancy BMI, being born large for gestational age, offspring level of sCD163, as well as offspring metabolic risk factors (decreasing adiponectin and HDL cholesterol and increasing leptin, HOMA of insulin resistance, and HOMA of insulin secretion) and degree of fatty liver.CONCLUSIONS: Intrauterine exposure to maternal type 1 diabetes and higher maternal prepregnancy BMI may predispose to fatty liver in the offspring. Offspring metabolic risk factors, including sCD163 levels, are associated with indices of fatty liver.

AB - OBJECTIVE: Intrauterine exposure to maternal type 1 diabetes is associated with a less favorable metabolic profile later in life. Nonalcoholic fatty liver disease is the hepatic manifestation of a cluster of metabolic abnormalities linked to insulin resistance. This study aimed to evaluate the effect of maternal pregestational type 1 diabetes on the presence of fatty liver in offspring and the association between maternal BMI, glycemic control during pregnancy, offspring metabolic risk factors, and offspring level of soluble CD163 (sCD163; a marker of macrophage activation) and risk of fatty liver.RESEARCH DESIGN AND METHODS: This study was a prospective nationwide follow-up study of offspring (n = 278) of mothers with pregestational type 1 diabetes between 1993 and 1999 and matched control subjects (n = 303). Mean age at the time of follow-up was 16.7 years (range 13.0-20.4 years). We used the fatty liver index (FLI) and waist-to-height ratio (WHtR) to evaluate the presence of fatty liver among the offspring. An FLI ≥60 or WHtR >0.469 were used as cutoff points for fatty liver.RESULTS: More type 1 diabetes-exposed offspring had high FLI and WHtR indices compared with unexposed control subjects. We found significant associations between increasing maternal prepregnancy BMI, being born large for gestational age, offspring level of sCD163, as well as offspring metabolic risk factors (decreasing adiponectin and HDL cholesterol and increasing leptin, HOMA of insulin resistance, and HOMA of insulin secretion) and degree of fatty liver.CONCLUSIONS: Intrauterine exposure to maternal type 1 diabetes and higher maternal prepregnancy BMI may predispose to fatty liver in the offspring. Offspring metabolic risk factors, including sCD163 levels, are associated with indices of fatty liver.

U2 - 10.2337/dc19-0571

DO - 10.2337/dc19-0571

M3 - Journal article

VL - 42

SP - 1560

EP - 1568

JO - International Journal of MS Care

JF - International Journal of MS Care

SN - 1935-5548

IS - 8

ER -

ID: 57863849